Comments on: Genzyme: Most Cerazyme Patients Resume Therapy http://www.pharmalot.com/2010/01/genzyme-most-cerazyme-patients-resume-therapy/ News, Comment and Conversation Fri, 10 Feb 2012 22:36:11 +0000 http://wordpress.org/?v=2.6.2 By: Joe http://www.pharmalot.com/2010/01/genzyme-most-cerazyme-patients-resume-therapy/#comment-458145 Joe Thu, 14 Jan 2010 21:07:46 +0000 http://www.pharmalot.com/?p=20887#comment-458145 Laura, Presumably, most of the other 20% are receiving one of two experimental drugs for Gaucher that FDA has okayed under an emergency access program. Laura,

Presumably, most of the other 20% are receiving one of two experimental drugs for Gaucher that FDA has okayed under an emergency access program.

]]> By: laura http://www.pharmalot.com/2010/01/genzyme-most-cerazyme-patients-resume-therapy/#comment-458001 laura Thu, 14 Jan 2010 00:57:22 +0000 http://www.pharmalot.com/?p=20887#comment-458001 Given the fact that Cerezyme is the only approved therapy for Gaucher's disease, should Termeer be crowing? What are the other 20 percent doing? This is frightening. Given the fact that Cerezyme is the only approved therapy for Gaucher’s disease, should Termeer be crowing? What are the other 20 percent doing?

This is frightening.

]]>